Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Edgewise Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $468.24M | $166.99M - $1.25B | $0.00 | $0.073 | 2 |
| Dec 2029 | $283.32M | $101.04M - $755.30M | $0.00 | $0.047 | 2 |
| Dec 2028 | $95.78M | $34.16M - $255.35M | $0.00 | -$1.611 | 5 |
| Dec 2027 | $29.73M | $2.55M - $100.11M | $0.00 | -$1.852 | 6 |
| Dec 2026 | $2.27M | $810.5K - $6.06M | $0.00 | -$1.937 | 5 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.596 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.489 | 0 |